Skip to main content
Clinical Trials/ACTRN12617001635358
ACTRN12617001635358
Not yet recruiting
Not Applicable

Safety of beta blocker commencement during acute exacerbations of chronic obstructive pulmonary disease (COPD) in patients with co-existing cardiovascular disease.

orthern Hospital0 sites40 target enrollmentDecember 18, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
orthern Hospital
Enrollment
40
Status
Not yet recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 18, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
orthern Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Early Beta blocker Administration before reperfusion in patients with ST-Elevation Myocardial Infarction who are planned to undergo primary PCI
NL-OMON41647Maatschap cardiologie Isala450
Active, not recruiting
Not Applicable
Early Beta blocker Administration before reperfusion in patients with a myocardial infarction who are planned to undergo a percutaneous coronary intervention within 12 hoursPatients with acute ST elevation myocardial infarction, scheduled for emergency coronary angioplastyMedDRA version: 16.1Level: LLTClassification code 10066641Term: Acute myocardial infarction, of anterior wallSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 16.1Level: LLTClassification code 10068109Term: Anterolateral myocardial infarctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 16.1Level: LLTClassification code 10000918Term: Acute myocardial infarction, of other specified sites, initial episode of careSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 16.1Level: PTClassification code 10028596Term: Myocardial infarctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 16.1Level: LLTClassification code 10066673Term: Transmural myocardial infarctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 16.1Level: LLTClassification code 10067273Term: Acute transmural myocardial infarctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 16.1Level: PTClassification code 10000891Term: Acute myocardial infarctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 16.1Level: LLTClassification code 10064345Term: ST segment elevation myocardial infarctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 16.1Level: LLTClassification code 10028597Term: Myocardial infarction acuteSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2010-023394-19-ESMaatschap Cardiologie Isala klinieken408
Active, not recruiting
Phase 1
Early Beta blocker Administration before reperfusion in patients with a myocardial infarction who are planned to undergo a percutaneous coronary intervention within 12 hoursPatients with acute ST elevation myocardial infarction, scheduled for emergency coronary angioplastyMedDRA version: 18.0Level: LLTClassification code 10066641Term: Acute myocardial infarction, of anterior wallSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2010-023394-19-NLMaatschap Cardiologie Isala601
Recruiting
Not Applicable
Early Beta blocker Administration before reperfusion in patients with ST-Elevation Myocardial Infarction who are planned to undergo primary PCI.Acute Myocardioal infarction, rescue PCI, prehospital treatment.Myocard infarktHartinfarkt
NL-OMON24992Maatschap Cardiologie Isala klinieken Zwolle408
Active, not recruiting
Phase 1
Assessment of Beta blocker interruption after uncomplicated mYocardial infarction : The ABYSS StudyMyocardial infarctionMedDRA version: 20.0 Level: PT Classification code 10028596 Term: Myocardial infarction System Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2017-003903-23-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)3,700